Co-Diagnostics, Inc.
CODX
$0.2981
-$0.002-0.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -80.09% | 170.47% | 51.58% | -18.55% | -58.02% |
| Total Other Revenue | -- | -100.00% | -81.29% | -- | -- |
| Total Revenue | -89.25% | -95.80% | -73.91% | 1,243.17% | -22.28% |
| Cost of Revenue | -90.79% | -91.40% | 16.26% | -53.80% | -53.31% |
| Gross Profit | -87.70% | -118.00% | -84.39% | 1,035.59% | 134.00% |
| SG&A Expenses | -23.48% | 12.10% | 5.84% | -23.38% | -5.04% |
| Depreciation & Amortization | -15.18% | 14.13% | 18.53% | 10.85% | 4.62% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -19.81% | -21.61% | -4.54% | -15.22% | 1.65% |
| Operating Income | 16.64% | -0.69% | -14.54% | 35.97% | -3.10% |
| Income Before Tax | 19.03% | -1.82% | -19.50% | 32.07% | -15.90% |
| Income Tax Expenses | -47.37% | -100.21% | 101.05% | 100.92% | 101.01% |
| Earnings from Continuing Operations | 19.10% | 24.84% | -62.09% | 14.79% | -61.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.10% | 24.84% | -62.09% | 14.79% | -61.80% |
| EBIT | 16.64% | -0.69% | -14.54% | 35.97% | -3.10% |
| EBITDA | 16.69% | -0.33% | -14.40% | 37.19% | -3.05% |
| EPS Basic | 24.65% | 28.27% | -56.11% | 17.71% | -59.84% |
| Normalized Basic EPS | 20.26% | 0.79% | -10.74% | 39.99% | -3.98% |
| EPS Diluted | 23.08% | 28.08% | -57.09% | 18.61% | -56.00% |
| Normalized Diluted EPS | 20.26% | 0.79% | -10.74% | 39.99% | -3.98% |
| Average Basic Shares Outstanding | 7.39% | 4.78% | 3.86% | 3.56% | 1.22% |
| Average Diluted Shares Outstanding | 7.39% | 4.78% | 3.86% | 3.56% | 1.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |